TEVAR can be a clinically successful treatment option for acute complicated type B aortic dissection with distal malperfusion syndrome.
TEVAR may be feasible for malperfusion in acute type B aortic dissection; hypothesis-generating and should not yet change practice.
Medical therapy remains the standard of care in the treatment of acute type B aortic dissection, despite its considerable long term complications. Since thoracic endovascular aortic repair (TEVAR) was introduced as an alternative treatment option for patients with type B aortic dissection in 1999, the use of TEVAR has been increasing in acute type B aortic dissection. However, acute complicated type B aortic dissections with distal malperfusion are a catastrophic process in association with life-threatening ischemia of the viscera and extremities. We are reporting a clinically successful result from the TEVAR used for malperfusion syndrome that occurred by acute type B aortic dissection.
No takes yet. Share an insight, caveat, or question.
Son et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: